Authors:
Topol, CE
Califf, RM
Simes, RJ
Van de Werf, F
Diaz, R
Paolasso, E
Aylward, PE
Keech, A
Klein, W
Piegas, L
Tomov, I
Armstrong, PW
Widimsky, P
Grande, P
Halinen, M
Vahanian, A
Neuhaus, K
Dimas, AP
Preda, I
Kristinsson, A
Tzivoni, D
Ardissino, D
White, HD
Madsen, S
Sugrue, D
Sadowski, Z
Seabra-Gomes, R
Apetrei, E
Dalby, A
Betriu, A
Pfisterer, M
Verheugt, F
Fox, K
Bates, ER
Gibler, WB
Granger, CB
Harrington, RA
Hochman, JS
Holmes, DR
Kleiman, NS
Lee, KL
Moliterno, DJ
Newby, LK
Ohman, EM
Califf, R
Newby, K
Zillman, L
Lee, K
Lemons, P
McCourt, B
Campbell, C
Tardiff, B
Snapp, J
Bassett, K
Hodgson, P
Hannan, K
Kandzari, L
Hawkins, S
Hinman-Smith, E
McDougal, M
Raffetto, K
Thompson, D
Wehrle, T
Ange, C
Brown, R
Grissom, G
Heuckel, M
McCall, J
Pennachi, W
Spychala, M
Veasey, S
Pullium, M
Journey, T
Quintero, K
Mark, D
Davidson-Ray, L
Diner, L
Nelson, C
Sowers, C
Webb, G
Young, M
Bhapkar, M
Pacchiana, C
Sparapani, R
Tuttle, R
Weaver, D
Borzak, S
Douthat, L
Topol, E
Moliterno, D
Konczos, L
Baishnab, R
Baishnab, R
Bakos, A
Blashford, L
Bratsch, J
Brown, K
Cadorini, E
Carlson, J
Clemmons, P
DelValle, M
Drabik, M
Fu, G
Gates, K
Gibson, Y
Heil, L
Hill, N
Klancar, R
McHale, B
Montague, E
Pasca, N
Pergi, L
Randall, R
Rosso, R
Sankovich, K
Smith, D
Wisniewski, L
Witkowski, M
Zovkic, V
Alexander, K
Bhatt, D
Brener, S
Campbell, L
Cho, L
Cole, C
Deedy, M
Foody, J
Gassler, J
Ghaffari, S
Haas, G
Kapadia, S
Lauer, M
Lauer, MS
Lincoff, M
Lutton, S
Marso, S
Mukherjee, D
Patel, V
Penn, M
Robbins, M
Roe, M
Sila, C
Thamilarasan, M
Wagner, G
Armstrong, P
Bestilny, S
Van de Werf, F
Budts, W
Graux, S
Luyten, A
Simes, J
Keech, A
Kava, M
Bower, T
Chan, S
Crampton, L
Monro, C
Nayak, M
Parente, G
Riley, V
Wilton, D
Aylward, P
Dolan, S
Thomas, C
White, H
Scott, M
Frye, R
Alpert, J
Bertrand, M
Ryan, T
Fisher, L
Asarch, L
Smith, M
Lim, L
Bokslag, M
Chiu, P
Chung, J
Collins, S
Dougherty, C
Guimaraes, D
Hakim, Z
Mathieson, J
Montgomery, L
Novotny, B
Steiner, B
Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Citation: L. Burnham et al., A rising temperature kinetic model to describe complex reaction kinetics of a drug: procainamide hydrochloride, THERMOC ACT, 357, 2000, pp. 15-22
Citation: K. Alexander et al., cis-Selective cyclopropanations using chiral 5,5-diaryl bis(oxazoline) catalysts, TETRAHEDR L, 41(36), 2000, pp. 7135-7138
Authors:
Jarvis, MF
Yu, HX
Kohlhaas, K
Alexander, K
Lee, CH
Jiang, MQ
Bhagwat, SS
Williams, M
Kowaluk, EA
Citation: Mf. Jarvis et al., ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse, J PHARM EXP, 295(3), 2000, pp. 1156-1164
Authors:
Alexander, K
Shaw, LJ
Shaw, LK
DeLong, E
Mark, D
Peterson, E
Citation: K. Alexander et al., Value of exercise treadmill testing in women. Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy (vol 32, pg 1657, 1998), J AM COL C, 33(1), 1999, pp. 269-269
Authors:
Brondolo, E
Karlin, W
Alexander, K
Bobrow, A
Schwartz, J
Citation: E. Brondolo et al., Workday communication and ambulatory blood pressure: Implications for the reactivity hypothesis, PSYCHOPHYSL, 36(1), 1999, pp. 86-94
Authors:
Lanphear, BP
Howard, C
Eberly, S
Auinger, P
Kolassa, J
Weitzman, M
Schaffer, SJ
Alexander, K
Citation: Bp. Lanphear et al., Primary prevention of childhood lead exposure: A randomized trial of dust control, PEDIATRICS, 103(4), 1999, pp. 772-777
Authors:
Alexander, K
Niforatos, W
Bianchi, B
Burgard, EC
Lynch, KJ
Kowaluk, EA
Jarvis, MF
van Biesen, T
Citation: K. Alexander et al., Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue, J PHARM EXP, 291(3), 1999, pp. 1135-1142